Neomycin nasal treatment shows promise against respiratory viruses

Summary: A Yale-led study found that neomycin, an over-the-counter antibiotic, delivered nasally, can prevent/treat respiratory viral infections in animals and trigger an immune response in humans. Published in Proceedings of the National Academy of Sciences, the research led by Akiko Iwasaki and Charles Dela Cruz showed promising results against COVID-19 and influenza. Neomycin treatment in mice and humans demonstrated effectiveness in combating viruses.

Full article